#6806 on the rich list of 14,644 insiders
Jared Gollob
Chief Medical Officer at Kymera Therapeutics. Based in Watertown, Massachusetts.
$14.0M
in disclosed stock, −$204K (−1.44%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 6806th of 14,644
- Companies held
- 1
- Largest holding
- KYMR, 100.0% of total
- Latest SEC filing
- Mar 4, 2026
What the $14.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kymera Therapeutics KYMR Common Stock | Directly | 117,134 | $119.39 | $14.0M | 100.0% | Form 4, Mar 4, 2026 |
Share counts are the amounts Jared Gollob reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Sold | KYMR | 1,437 | $85.78 | $123K | View |
| Mar 4, 2026 | Sold | KYMR | 492 | $84.00 | $41K | View |
| Mar 4, 2026 | Sold | KYMR | 2,519 | $85.04 | $214K | View |
| Mar 4, 2026 | Sold | KYMR | 447 | $86.62 | $39K | View |
| Mar 2, 2026 | Sold | KYMR | 3,048 | $89.66 | $273K | View |
| Mar 2, 2026 | Sold | KYMR | 1,055 | $88.50 | $93K | View |
| Mar 2, 2026 | Sold | KYMR | 1,510 | $87.75 | $133K | View |
| Dec 8, 2025 | Sold | KYMR | 3,300 | $91.46 | $302K | View |
| Dec 8, 2025 | Sold | KYMR | 8,562 | $90.12 | $772K | View |
| Dec 8, 2025 | Sold | KYMR | 3,929 | $89.43 | $351K | View |
| Dec 8, 2025 | Sold | KYMR | 18,357 | $88.02 | $1.6M | View |
| Dec 8, 2025 | Sold | KYMR | 13,759 | $87.37 | $1.2M | View |
| Dec 8, 2025 | Sold | KYMR | 1,400 | $92.19 | $129K | View |
| Oct 15, 2025 | Sold | KYMR | 29,264 | $60.37 | $1.8M | View |
| Oct 15, 2025 | Sold | KYMR | 6,453 | $63.09 | $407K | View |
| Oct 15, 2025 | Sold | KYMR | 14,896 | $62.72 | $934K | View |
| Oct 15, 2025 | Sold | KYMR | 8,963 | $61.49 | $551K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6803 | Gregory Orenstein CFO & Treasurer, nCino. Wilmington, NC | $14.0M |
| 6804 | Steven Blum EVP, Chief Operating Officer, Autodesk. San Francisco, CA | $14.0M |
| 6805 | Christopher Paul Riley Executive Vice President, Danaher. Washington, DC | $14.0M |
| 6806 | Jared Gollob Chief Medical Officer, Kymera Therapeutics. Watertown, MA | $14.0M |
| 6807 | Timothy A. Welsh Vice Chair, U.S. Bancorp. Minneapolis, MN | $14.0M |
| 6808 | Stanley J. Bradshaw Director, First Busey. Leawood, KS | $14.0M |
| 6809 | Sharon R. Barner VP - Chief Administrative Off., Cummins. Pittsburgh, PA | $14.0M |
Other Kymera Therapeutics insiders
All KYMR insiders- Nello Mainolfi$79.6MChief Executive Officer. #1805 overall
- Bruce N. Jacobs$29.2MChief Financial Officer. #3858 overall
- Ellen Chiniara$9.6MChief Legal Officer. #9085 overall
- Brian Adams$6.0MChief Legal Officer. #7698 overall
- Noah Goodman$5.6MChief Business Officer. #13319 overall
- Jeremy G. Chadwick$5.3MChief Operating Officer. #13964 overall
Questions
How much stock does Jared Gollob own?
Jared Gollob holds $13,984,628 in listed stock based on SEC filings and current prices, mostly Kymera Therapeutics (KYMR). That ranks 6806th on the Stock Rich List.
Is this Jared Gollob's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jared Gollob last buy or sell stock?
The most recent open-market trade on file is a sale of 1,437 KYMR shares on Mar 4, 2026 at $85.78.